case_images: PMC5437432_01
case_images: Fluorescein angiography showed profound macular and peripheral ischemia in the early phase (left), in the middle phase (middle), and in the late phase (right, composite view).
case_images: cop-0008-0271-g01.jpg
case_images: PMC5437432_01_cop-0008-0271-g01.jpg
case_images: F1
case_images: Fluorescein angiography (FAG) showed an acute BRVO with ischemia in the macular area and along the inferior temporal retinal arcade (Fig. 1).
case_images: Intravitreal injections, development of BCVA and CRT, and corresponding OCT images between April 2014 and October 2016.
case_images: cop-0008-0271-g02.jpg
case_images: PMC5437432_01_cop-0008-0271-g02.jpg
case_images: F2
case_images: Optical coherence tomography (OCT) analysis detected a central retinal thickness (CRT) of 546 microm (Fig. 2). At the last visit, ME had again completely resolved and BCVA increased to 0.6 (Fig. 2).
case_images: Follow-up fluorescein angiography showed profound macular and peripheral ischemia in the early phase (left), in the middle phase (middle), and in the late phase (right, composite view).
case_images: cop-0008-0271-g03.jpg
case_images: PMC5437432_01_cop-0008-0271-g03.jpg
case_images: F3
case_images: A follow-up FAG in August 2014 and in September 2016 (Fig. 3) showed no changes in central retinal ischemia status; there was neither a decrease nor an increase in the size of the central ischemic retinal area.